RedHill Reports 3Q/2021 Financial Results

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial ResultsRedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against OmicronActing independently of spike protein mutation, …